Category: W.L. Gore & AssociatesSyndicate content

Appeals court upholds win for Gore in patent war with STJ | Medtech legal news for the week of June 16, 2014

June 16, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Appeals court upholds Gore win over St. Jude Medical; Independent legal panel rejects Infuse allegations in Medtronic shareholder suits; Judge dismisses Anulex from Xclose off-label lawsuit; Appeals court upholds Abiomed win in shareholder's class action; Convicted ex-Heart Tronics CEO won't get a retrial, judge rules.

Appeals court upholds Gore win over St. Jude Medical

June 9, 2014 by Brad Perriello

Appeals court upholds Gore win over St. Jude Medical

Appeals court upholds Gore win over St. Jude Medical

June 9, 2014 by Brad Perriello

A federal appeals court upholds W.L. Gore & Assoc.'s win over St. Jude Medical in their patent spat over heart defect repair technology.

Appeals court upholds Gore win over St. Jude Medical

A federal appeals court today upheld a win for W.L. Gore & Assoc. in a patent war with St. Jude Medical (NYSE:STJ) over heart defect repair technology.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Gore's Viabahn stent graft bests angioplasty, study finds

February 20, 2014 by Arezu Sarvestani

W.L. Gore's newly approved drug-coated Viabahn stent graft beat the current standard of care in treating patients with stenoses or thrombotic occlusions, according to the REVISE clinical study findings.

Gore's Viabahn stent graft bests angioplasty, study finds

Arizona medical device maker W.L. Gore & Assoc. teased positive results from its REVISE clinical trial, promising to release additional findings during the American Society of Diagnostic & Interventional Nephrology meeting in Phoenix this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Legal win, buyouts boost Bard's bottom line

February 3, 2014 by Brian Johnson

C.R. Bard's 4th-quarter bottom line gets a significant boost from a nearly $900 million legal payment from rival W.L. Gore and the more than $200 million gain from selling its electrophysiology business to Boston Scientific.

A nearly $900 million award from W.L. Gore boosted C.R. Bard's bottom line in Q4 as sales inch up 3% in 2013: Officials announce $500 million share buyback plan.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Gore opens U.S. endoprosthesis trial

January 30, 2014 by Chris Walker

W.L. Gore enrolls its 1st patient in the Gore TAG thoracic branch endoprosthesis LSA feasibility study in the U.S.

Gore opens endoprosthesis trial

W.L. Gore & Associates enrolled the 1st patient in its U.S. Gore TAG thoracic branch endoprosthesis LSA feasibility study in hopes of landing FDA approval for treatment of thoracic aortic aneurysms in the left subclavian artery.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Gore appeals $860M loss to Bard

December 12, 2013 by Brad Perriello

W.L. Gore & Assoc. appeals its $860 million patent infringement loss to C.R. Bard over stent graft technology.

Gore appeals $860M loss to Bard

C.R. Bard (NYSE:BCR) had no standing to bring the patent infringement lawsuit that won it a nearly $860 million verdict against W.L. Gore & Assoc., Gore argued in its appeal yesterday.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Gore lands FDA expanded approval for Viabahn endoprosthesis

December 11, 2013 by Arezu Sarvestani

W.L. Gore touts expanded approval to market its Viabahn endoprosthesis to treat stenosis and thrombosis in synthetic vascular access grafts.

Gore lands FDA expanded approval for Viabahn endoprosthesis

W.L. Gore & Associates today touted expanded FDA approval for its Viabahn endoprosthesis, now indicated for treatment of stenosis and thrombotic occlusions related to synthetic vascular access grafts.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp